Javascript must be enabled to continue!
ECMO physiology
View through CrossRef
Temporary mechanical cardiopulmonary support may be used intraoperatively to facilitate cardiac surgery. Over the past decade, this intervention has been extended for prolonged use in the intensive care unit (ICU) as extracorporeal membrane oxygenation (ECMO).
1
Two types of ECMO exist in clinical practice: veno-arterial (VA) and veno-venous (VV). VV ECMO provides support to the pulmonary system by extracting blood from the right atrium, oxygenating it and returning it to the right atrium, where the patient remains dependent on their own circulation. In VA ECMO, blood is extracted from the right atrium and returned to the arterial system, bypassing the heart and lungs, which provides both respiratory and hemodynamic support.
2
Patients who require ECMO support receive anticoagulation with heparin
3
before the cannulas are inserted, either in the right jugular area or in the left/right femoral area(s). In VV ECMO, blood is drained from the venous cannula placed typically in the inferior vena cava (IVC), and returned through a cannula with its tip at close proximity of the right atrium, either through the femoral vein or through the right internal jugular vein. In VA ECMO, blood is drained from the IVC and returned through right femoral artery or the aorta to the systemic cannulation.
2
ECMO support is initiated when the patient is connected to the ECMO circuit. The deoxygenated blood will be withdrawn from the patient through the access line under negative pressure (usually created by a centrifugal pump) entering the oxygenator (artificial lung membrane), where gas exchange occurs. Blood is then returned back to the patient through the return line.
4
Oxygenated Flow on ECMO machine is controlled across the hollow fiber membrane. The blood flows outside of the fibers and the gas flows through the fibers in a counter current flow pattern. The non-direct contact between blood and gas reduces blood trauma. The gas exchange occurs through diffusion due to the concentration gradient between O
2
and CO
2
. Oxygenated blood is then returned back to the patient through the return line.
4
Pressures within an ECMO circuit are highly important and need to be understood (access, pre-membrane, and post-membrane pressures) to quickly identify potential issues. The transmembrane pressure (TMP) is the difference between the pre- and post-membrane pressures. The TMP baseline should be monitored when ECMO is initiated and be compared with the TMP trend during the ECMO run, as it reflects the function of the circuit membrane. The membrane acts as the blood oxygenator and should be regularly checked for clots.
The patient oxygen saturation, temperature, hemoglobin, sedation, preload, and afterload will be continuously monitored. FiO
2
and sweep gas flow is adjusted according to pre- and post-membrane blood gases.
Anticoagulation is sustained while the patient is on ECMO and it is monitored through the activated clotting time (ACT). ACT of 180–210 seconds or APTT of 35–45 seconds are accepted.
3
The use of Bioline coating on the internal circuit surfaces improves biocompatibility of extracorporeal circulation system devices: oxygenators, cannulas, connectors, centrifugal pumps, and tubes by mimicking human tissue.
It is highly important to understand the possible complications that may occur while patients are on ECMO, whether it is patient related (bleeding, thromboembolism, etc.) or ECMO circuit related.
1
Therefore, all safety devices within an ECMO machine and circuit should be connected properly, functioning well, and checked continuously until the patient is weaned from ECMO.
4
Hamad bin Khalifa University Press (HBKU Press)
Title: ECMO physiology
Description:
Temporary mechanical cardiopulmonary support may be used intraoperatively to facilitate cardiac surgery.
Over the past decade, this intervention has been extended for prolonged use in the intensive care unit (ICU) as extracorporeal membrane oxygenation (ECMO).
1
Two types of ECMO exist in clinical practice: veno-arterial (VA) and veno-venous (VV).
VV ECMO provides support to the pulmonary system by extracting blood from the right atrium, oxygenating it and returning it to the right atrium, where the patient remains dependent on their own circulation.
In VA ECMO, blood is extracted from the right atrium and returned to the arterial system, bypassing the heart and lungs, which provides both respiratory and hemodynamic support.
2
Patients who require ECMO support receive anticoagulation with heparin
3
before the cannulas are inserted, either in the right jugular area or in the left/right femoral area(s).
In VV ECMO, blood is drained from the venous cannula placed typically in the inferior vena cava (IVC), and returned through a cannula with its tip at close proximity of the right atrium, either through the femoral vein or through the right internal jugular vein.
In VA ECMO, blood is drained from the IVC and returned through right femoral artery or the aorta to the systemic cannulation.
2
ECMO support is initiated when the patient is connected to the ECMO circuit.
The deoxygenated blood will be withdrawn from the patient through the access line under negative pressure (usually created by a centrifugal pump) entering the oxygenator (artificial lung membrane), where gas exchange occurs.
Blood is then returned back to the patient through the return line.
4
Oxygenated Flow on ECMO machine is controlled across the hollow fiber membrane.
The blood flows outside of the fibers and the gas flows through the fibers in a counter current flow pattern.
The non-direct contact between blood and gas reduces blood trauma.
The gas exchange occurs through diffusion due to the concentration gradient between O
2
and CO
2
.
Oxygenated blood is then returned back to the patient through the return line.
4
Pressures within an ECMO circuit are highly important and need to be understood (access, pre-membrane, and post-membrane pressures) to quickly identify potential issues.
The transmembrane pressure (TMP) is the difference between the pre- and post-membrane pressures.
The TMP baseline should be monitored when ECMO is initiated and be compared with the TMP trend during the ECMO run, as it reflects the function of the circuit membrane.
The membrane acts as the blood oxygenator and should be regularly checked for clots.
The patient oxygen saturation, temperature, hemoglobin, sedation, preload, and afterload will be continuously monitored.
FiO
2
and sweep gas flow is adjusted according to pre- and post-membrane blood gases.
Anticoagulation is sustained while the patient is on ECMO and it is monitored through the activated clotting time (ACT).
ACT of 180–210 seconds or APTT of 35–45 seconds are accepted.
3
The use of Bioline coating on the internal circuit surfaces improves biocompatibility of extracorporeal circulation system devices: oxygenators, cannulas, connectors, centrifugal pumps, and tubes by mimicking human tissue.
It is highly important to understand the possible complications that may occur while patients are on ECMO, whether it is patient related (bleeding, thromboembolism, etc.
) or ECMO circuit related.
1
Therefore, all safety devices within an ECMO machine and circuit should be connected properly, functioning well, and checked continuously until the patient is weaned from ECMO.
4.
Related Results
Hemodynamic analysis of left ventricular unloading with Impella versus IABP during VA-ECMO
Hemodynamic analysis of left ventricular unloading with Impella versus IABP during VA-ECMO
Purpose
The utilization of intra-aortic balloon pump (IABP) and Impella has been suggested as means of left ventricular unloading in veno-arterial extracorporeal membrane oxyg...
Application of in Vitro Membrane Pulmonary Oxygenation Technology (ECMO) in Neonatal Respiratory Failure
Application of in Vitro Membrane Pulmonary Oxygenation Technology (ECMO) in Neonatal Respiratory Failure
Objective: To explore the application of Extracorporeal Membrane Oxygenation technology (ECMO) in neonatal respiratory failure and provide guidance for future ECMO technology for c...
Brief Overview of the Use of Extracorporeal Membrane Oxygenation (ECMO) in COVID-19 Patients with Severe Acute Respiratory Distress Syndrome (ARDS)
Brief Overview of the Use of Extracorporeal Membrane Oxygenation (ECMO) in COVID-19 Patients with Severe Acute Respiratory Distress Syndrome (ARDS)
Background
A serious complication of coronavirus disease 2019 (COVID-19) is acute respiratory distress syndrome (ARDS). Hypoxemia refractory to traditional management, including in...
Abdominal Surgery Needs Extracorporeal Life Support as a Final Back-up
Abdominal Surgery Needs Extracorporeal Life Support as a Final Back-up
Abstract
Background: There are very limited published data regarding the experience of extracorporeal membrane oxygenation (ECMO) after abdominal surgery. Our objective was...
Combined use of VA-ECMO and IMPELLA (ECPELLA) as a possible strategy to improve outcomes in patients who underwent E-CPR
Combined use of VA-ECMO and IMPELLA (ECPELLA) as a possible strategy to improve outcomes in patients who underwent E-CPR
Abstract
Background
Extracorporeal Cardio-Pulmonary Resuscitation (E-CPR) is an effective tool for patients with refractory card...
Desafios da assistência de enfermagem no tratamento da COVID-19 em pacientes com uso da ECMO
Desafios da assistência de enfermagem no tratamento da COVID-19 em pacientes com uso da ECMO
Descrever os principais desafios da assistência de enfermagem no tratamento da COVID-19 em pacientes com a terapia de circulação extracorpórea com oxigenador de membrana Ecmo. O M...
Characteristics and outcomes of combination VA-ECMO for cardiogenic shock
Characteristics and outcomes of combination VA-ECMO for cardiogenic shock
Abstract
Background
Use of VA-ECMO for cardiogenic shock is growing exponentially. The impact of VA-ECMO on in-hospital mortalit...
Safety and Efficacy of Recombinant Factor VIIa (NovoSeven) Use during ECMO Support in Patients after Cardiac Surgery
Safety and Efficacy of Recombinant Factor VIIa (NovoSeven) Use during ECMO Support in Patients after Cardiac Surgery
Background: Acute postoperative bleeding in cardiac surgical patients is a major cause of morbidity and mortality. Substitution of coagulatory factors may not always provide optima...

